JP2022530192A5 - - Google Patents
Info
- Publication number
- JP2022530192A5 JP2022530192A5 JP2021560095A JP2021560095A JP2022530192A5 JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5 JP 2021560095 A JP2021560095 A JP 2021560095A JP 2021560095 A JP2021560095 A JP 2021560095A JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- helper
- gene
- functional
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19169121.1 | 2019-04-12 | ||
| GBGB1905263.8A GB201905263D0 (en) | 2019-04-12 | 2019-04-12 | Plasmid system |
| EP19169121.1A EP3722434B2 (en) | 2019-04-12 | 2019-04-12 | Plasmid system |
| GB1905263.8 | 2019-04-12 | ||
| PCT/GB2020/050947 WO2020208379A1 (en) | 2019-04-12 | 2020-04-14 | Plasmid system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530192A JP2022530192A (ja) | 2022-06-28 |
| JP2022530192A5 true JP2022530192A5 (cg-RX-API-DMAC7.html) | 2023-04-17 |
| JP7562558B2 JP7562558B2 (ja) | 2024-10-07 |
Family
ID=70295566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560095A Active JP7562558B2 (ja) | 2019-04-12 | 2020-04-14 | プラスミドシステム |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220162642A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3953482A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7562558B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220019669A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113891942A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020272557B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021020401A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3136545A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL296544A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111149VA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020208379A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001593A (es) | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| JP7602454B2 (ja) | 2018-08-09 | 2024-12-18 | バイオベラティブ セラピューティクス インコーポレイテッド | 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用 |
| PL3722434T3 (pl) | 2019-04-12 | 2022-12-12 | Freeline Therapeutics Limited | Układ plazmidowy |
| WO2021084276A2 (en) | 2019-11-01 | 2021-05-06 | Freeline Therapeutics Limited | Factor viii construct |
| WO2022159702A1 (en) * | 2021-01-22 | 2022-07-28 | Biogen Ma Inc. | Microtubule destabilizer additives to increase recombinant viral vector titers |
| WO2022182986A1 (en) * | 2021-02-26 | 2022-09-01 | Logicbio Therapeutics, Inc. | Manufacturing and use of recombinant aav vectors |
| EP4410971A4 (en) * | 2021-09-30 | 2025-06-04 | FUJIFILM Corporation | METHOD FOR PRODUCING AN ADENO-ASSOCIATED VIRUS, CELLS AND EXPRESSION VECTOR |
| GB202214328D0 (en) | 2022-09-29 | 2022-11-16 | Freeline Therapeutics Ltd | Method |
| WO2024160232A1 (zh) * | 2023-02-01 | 2024-08-08 | 纽福斯(苏州)生物科技有限公司 | 质粒包装系统及其应用 |
| CN118633572B (zh) * | 2023-03-06 | 2026-07-21 | 北京锦篮基因科技股份有限公司 | 神经元核内包涵体病小鼠模型构建方法及应用 |
| WO2024223931A1 (en) * | 2023-04-28 | 2024-10-31 | AstraZeneca Ireland Limited | Manufacturing and use of recombinant self-complementary aav vectors |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| WO2025083617A1 (en) * | 2023-10-18 | 2025-04-24 | Nanocell Therapeutics Holdings B.V. | Methods and compositions for nucleic construct delivery |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| TW202548023A (zh) | 2024-03-14 | 2025-12-16 | 美商雅菲納治療公司 | 用於生產重組腺相關病毒的質體系統 |
| EP4628576A1 (en) | 2024-04-07 | 2025-10-08 | Ascend Advanced Therapies GmbH | Microrna molecules for use in methods for improving recombinant aav production |
| WO2025238067A1 (en) | 2024-05-15 | 2025-11-20 | Ascend Advanced Therapies Gmbh | Novel vector system for aav production |
| EP4752226A1 (en) | 2024-11-28 | 2026-06-03 | Ascend Advanced Therapies GmbH | Plasmid system for aav production |
| WO2026064428A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026064444A1 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026109693A1 (en) | 2024-11-21 | 2026-05-28 | Ascend Advanced Therapies Ltd | Method for improved aav production |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10066104A1 (de) | 2000-09-08 | 2003-01-09 | Medigene Ag | Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung |
| CA2453405A1 (en) * | 2001-07-13 | 2003-01-23 | University Of Iowa Research Foundation | Pseudotyped adeno-associated viruses and uses thereof |
| AU2002352195A1 (en) * | 2001-11-30 | 2003-06-10 | Medigene Aktiengesellschaft | Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
| ES2330826B1 (es) * | 2008-06-04 | 2010-07-26 | Proyecto De Biomedicina Cima, S.L. | Sistema para empaquetamiento de adenovirus de alta capacidad. |
| CA2754335C (en) * | 2009-03-04 | 2019-12-24 | Medigene Ag | Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3 |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| EP2782596A4 (en) | 2011-11-22 | 2015-07-29 | Philadelphia Children Hospital | VIRUS VECTORS FOR HIGHLY EFFICIENT TRANSGENIC ADMINISTRATION |
| GB201420139D0 (en) | 2014-11-12 | 2014-12-24 | Ucl Business Plc | Factor IX gene therapy |
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| WO2017096164A1 (en) | 2015-12-02 | 2017-06-08 | The Board Of Trustees Of The Leland Stanford Junior University | Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism |
| CN108048483B (zh) * | 2018-01-30 | 2021-02-02 | 中国疾病预防控制中心病毒病预防控制所 | 复制型重组腺病毒HAdV-5载体系统及其应用 |
-
2020
- 2020-04-14 CA CA3136545A patent/CA3136545A1/en active Pending
- 2020-04-14 SG SG11202111149VA patent/SG11202111149VA/en unknown
- 2020-04-14 JP JP2021560095A patent/JP7562558B2/ja active Active
- 2020-04-14 US US17/602,941 patent/US20220162642A1/en not_active Abandoned
- 2020-04-14 WO PCT/GB2020/050947 patent/WO2020208379A1/en not_active Ceased
- 2020-04-14 EP EP20720111.2A patent/EP3953482A1/en active Pending
- 2020-04-14 AU AU2020272557A patent/AU2020272557B2/en active Active
- 2020-04-14 KR KR1020217037076A patent/KR20220019669A/ko active Pending
- 2020-04-14 BR BR112021020401A patent/BR112021020401A2/pt unknown
- 2020-04-14 IL IL296544A patent/IL296544A/en unknown
- 2020-04-14 CN CN202080039790.8A patent/CN113891942A/zh active Pending
-
2021
- 2021-10-07 IL IL287100A patent/IL287100A/en unknown
-
2025
- 2025-11-06 US US19/381,401 patent/US20260117255A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7796702B2 (ja) | スペーサーを含む核酸分子およびその使用の方法 | |
| JP2022530544A5 (cg-RX-API-DMAC7.html) | ||
| JP6174318B2 (ja) | アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物 | |
| Grieger et al. | Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications | |
| JP2022530656A5 (cg-RX-API-DMAC7.html) | ||
| US7220577B2 (en) | Modified AAV | |
| US8409842B2 (en) | Recombinant adeno-associated virus production | |
| JP2021515548A5 (cg-RX-API-DMAC7.html) | ||
| JP2018108113A5 (cg-RX-API-DMAC7.html) | ||
| CA2303768A1 (en) | Methods and vector constructs useful for production of recombinant aav | |
| CA2349838A1 (en) | Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same | |
| US20250236888A1 (en) | Recombinant parvoviral vectors and method of making and use thereof | |
| JP2001512674A (ja) | 組換えaavの生産効率を増強する方法 | |
| GB2592752A (en) | DNA amplification method | |
| CA3218360A1 (en) | System for high-level raav production | |
| CN119487183A (zh) | 用于生产重组细小病毒的组合物和方法 | |
| JP2025516599A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2023214579A5 (cg-RX-API-DMAC7.html) | ||
| Smith et al. | Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid | |
| JP2024519175A5 (cg-RX-API-DMAC7.html) | ||
| CN119842817A (zh) | 一种用于生产重组腺相关病毒的新型辅助质粒及其构建方法和应用 | |
| US7148341B2 (en) | AAV DNA comprising helper virus sequences | |
| CN119569834A (zh) | 靶向心肌细胞的aav衣壳蛋白变体及其用途 | |
| CN114736928A (zh) | 一种杆状病毒载体及其在昆虫细胞中制备rAAV的应用 | |
| JP2024546578A5 (cg-RX-API-DMAC7.html) |